| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | pachytene | 1.06e-05 | 4 | 28 | 2 | GO:0000239 | |
| GeneOntologyBiologicalProcess | prophase | 7.94e-05 | 10 | 28 | 2 | GO:0051324 | |
| GeneOntologyBiologicalProcess | meiotic prophase I | 7.94e-05 | 10 | 28 | 2 | GO:0007128 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle phase | 1.16e-04 | 12 | 28 | 2 | GO:0098764 | |
| GeneOntologyBiologicalProcess | M phase | 1.60e-04 | 14 | 28 | 2 | GO:0000279 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle phase | 1.60e-04 | 14 | 28 | 2 | GO:0098762 | |
| Pubmed | 1.08e-04 | 107 | 30 | 3 | 11347906 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.13e-04 | 1105 | 30 | 6 | 35748872 | |
| Pubmed | 3.29e-04 | 156 | 30 | 3 | 29961565 | ||
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 175 | 30 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| Disease | severe aplastic anemia | 9.05e-05 | 15 | 28 | 2 | EFO_0006927 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 1.98e-04 | 22 | 28 | 2 | EFO_0009312 | |
| Disease | airway responsiveness measurement | 2.37e-04 | 24 | 28 | 2 | EFO_0006897 | |
| Disease | cognitive impairment measurement | 8.01e-04 | 44 | 28 | 2 | EFO_0007998 | |
| Disease | homocysteine measurement | 8.76e-04 | 46 | 28 | 2 | EFO_0004578 | |
| Disease | Amphetamine Abuse | 2.31e-03 | 75 | 28 | 2 | C0236807 | |
| Disease | Amphetamine Addiction | 2.31e-03 | 75 | 28 | 2 | C0236804 | |
| Disease | Amphetamine-Related Disorders | 2.31e-03 | 75 | 28 | 2 | C0236733 | |
| Disease | eosinophil count | 2.35e-03 | 1488 | 28 | 6 | EFO_0004842 | |
| Disease | neutrophil percentage of leukocytes | 2.50e-03 | 610 | 28 | 4 | EFO_0007990 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.59e-03 | 291 | 28 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | calcium measurement | 2.77e-03 | 628 | 28 | 4 | EFO_0004838 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 3.24e-03 | 315 | 28 | 3 | EFO_0004574, EFO_0004612 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.38e-03 | 91 | 28 | 2 | EFO_0004611, EFO_0005271 | |
| Disease | mitochondrial DNA measurement | 3.63e-03 | 328 | 28 | 3 | EFO_0006312 | |
| Disease | lipoprotein A measurement | 5.06e-03 | 112 | 28 | 2 | EFO_0006925 | |
| Disease | neuroblastoma | 5.42e-03 | 116 | 28 | 2 | EFO_0000621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLKGLGLHCPTYHNP | 291 | Q9H172 | |
| RYAAPYCSLTHPLKN | 2426 | Q96PZ7 | |
| HCYGPYPIPKLTEIK | 891 | A6QL63 | |
| CYEHYGIRLPKKGKP | 11 | Q9BUB4 | |
| DLCGPYYPEHCLPKK | 1701 | Q7Z5J4 | |
| KLLPYCRGNILPHTY | 166 | Q8NGI2 | |
| LGTYASLHGRIYCKP | 426 | Q9UHB6 | |
| LKDYVSGKLLYCHPP | 536 | Q9H089 | |
| KCTKSLPYEPYKALH | 136 | Q96GV9 | |
| YKALHGPLPLCLLKG | 146 | Q96GV9 | |
| AYLAHKKYSCPAAPP | 831 | Q8IX07 | |
| AHPPLCLKSKYQSYR | 361 | O75023 | |
| PGLSKFRLSYYPHCL | 236 | Q14749 | |
| KPSPTLYHCPLYKTG | 4101 | Q9C0G6 | |
| KLYHVPSYLPKSLLH | 546 | O94769 | |
| AQYKKICPHGPGYTT | 2431 | P35556 | |
| KHCLSYLPALSPVYF | 1826 | O95180 | |
| TALHSPGPKCKLLYY | 636 | O43304 | |
| LRCLHKFTSSLPKYP | 416 | Q9UBD5 | |
| KPLYANRCHYVPKTS | 121 | Q5JRV8 | |
| YPCILYGILPAKGKH | 1846 | B5MCY1 | |
| PAPCKYAHKLAFLSG | 941 | Q8TC59 | |
| KELYPGQFKPTICHY | 136 | Q8IXJ6 | |
| IHDTFLKLCPPGKYY | 31 | A0PJX0 | |
| KNPCLLPYGKALYSY | 191 | Q8TEJ3 | |
| YFLYSPVHCRPELKK | 1296 | A6NE52 | |
| CPKAFSYPSKLAAHR | 96 | Q86XF7 | |
| HCYVGLPFLSKSEPK | 751 | Q92545 | |
| KVKGSPSHCLPYLLD | 46 | A0A1B0GTY4 | |
| HYKSALSLGCYPPLE | 1556 | Q8N9V7 | |
| ASLNATKLKHPYYPC | 2146 | Q9UPU5 | |
| RVLYLYPTHKSLKPC | 166 | Q8N5A5 |